Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group CoFRA:L97 -1.53%84 5-Year Yield-on-Cost % is 3.62 as of Aug. 21, 2026, which is 183% above its 10-year median of 1.28. GuruFocus rates FRA:L97 with a GF Score™ of 84/100 and a GF Value™ of €0.21. The stock has 7 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 55.6% on this metric.
The historical rank and industry rank for Yonghe Medical Group Co's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:L97'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.8 Med: 1.28 Max: 3.74
Current: 3.62
During the past 8 years, Yonghe Medical Group Co's highest Yield on Cost was 3.74. The lowest was 0.80. And the median was 1.28.
FRA:L97's 5-Year Yield-on-Cost % is ranked better than 55.6% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 3.04
vs FRA:L97: 3.62
Yonghe Medical Group Co (FRA:L97) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Yonghe Medical Group Co 5-Year Yield-on-Cost % Related Terms
FRA:L97 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's 5-Year Yield-on-Cost % falls into.
Yonghe Medical Group Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Yonghe Medical Group Co (FRA:L97) has a 5-Year Yield-on-Cost % of 3.62 as of Aug. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Yonghe Medical Group Co and its competitors. This is 183% above median its historical median of 1.28. Over the past decade, Yonghe Medical Group Co's 5-Year Yield-on-Cost % has ranged from 0.80 to 3.74. According to the industry distribution chart, Yonghe Medical Group Co ranks #123 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 44.4%.
Is Yonghe Medical Group Co's 5-Year Yield-on-Cost % too high?
Yonghe Medical Group Co's current 5-Year Yield-on-Cost % of 3.62 is 183% above median its 10-year median of 1.28. Over the past 10 years, this metric has ranged from a low of 0.80 to a high of 3.74. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 3.04. Yonghe Medical Group Co's value of 3.62 is 19.1% above this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #123 out of 277 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #123 out of 277 companies for 5-Year Yield-on-Cost %. This puts Yonghe Medical Group Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.04. Yonghe Medical Group Co's value of 3.62 is 19.1% above this benchmark. Historically, Yonghe Medical Group Co's own 5-Year Yield-on-Cost % has ranged from 0.80 to 3.74 over the past decade. While the company's 10-year median is 1.28 vs. the industry median of 3.04, Yonghe Medical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 3.04, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current 5-Year Yield-on-Cost % of 3.62 is 19.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 3.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current 5-Year Yield-on-Cost % is 3.62, which is 183% above median its own 10-year median of 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (FRA:L97) has a current 5-Year Yield-on-Cost % of 3.62. The stock's GF Value™ is €0.21, compared to a current price of €0.26 — trading 22.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 3.62, which is 183% above median its 10-year median of 1.28 and 19.1% above the Healthcare Providers & Services industry median of 3.04. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Yonghe Medical Group Co (FRA:L97), the current 5-Year Yield-on-Cost % is 3.62 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (FRA:L97) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of €0.26 is trading 22.9% above its estimated GF Value™ of €0.21.
Key valuation signals for FRA:L97:
5-Year Yield-on-Cost %: 3.62 (183% above median its 10-year median of 1.28)
GF Value™: €0.21 vs. price of €0.26 (22.9% above fair value)
Industry Position: 19.1% above the Healthcare Providers & Services median (#123 of 277)
No single metric tells the full story. See the FRA:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for FRA:L97
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L97 has been successfully added to your 
